Other highlights for the quarter include a sharp increase in royalties and profit sharing from the blood pressure drugs Cozaar and Hyzaar under an exclusive ...
... from the US Food and Drug Administration to market its generic version of Merck & Co Inc's antihypertensive agent Cozaar (losartan potassium) tablets. ...